D47.3 - Essential (hemorrhagic) thrombocythemia
- Applicable to Essential (hemorrhagic) thrombocythemia
- The 2025 edition of ICD10-CM D47.3 became effective on October 1, 2024.
- This is the American ICD10-CM version of D47.3 - other international versions of ICD10 D47.3 may differ.
- D47.3 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Essential thrombocytosis
- Idiopathic hemorrhagic thrombocythemia
- Primary thrombocytosis
Type 2 Excludes
- reactive thrombocytosis (D75.838)
- secondary thrombocytosis (D75.838)
- thrombocythemia NOS (D75.839)
- thrombocytosis NOS (D75.839)
Billable/Specific Code
The following codes above D47.3 contain annotation back-references that may be applicable to D47.3:
- Chapter: C00-D49 - Neoplasms
- Section: D37-D48 - Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
- Category: D47 - Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com